354 related articles for article (PubMed ID: 33824220)
1. [Application of CGRP-Related Monoclonal Antibodies in Migraine Management].
Shibata M
Brain Nerve; 2021 Apr; 73(4):327-337. PubMed ID: 33824220
[TBL] [Abstract][Full Text] [Related]
2. [Novel migraine treatment with CGRP-related monoclonal antibodies].
Shibata M
Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
[TBL] [Abstract][Full Text] [Related]
3. CGRP and the Trigeminal System in Migraine.
Iyengar S; Johnson KW; Ossipov MH; Aurora SK
Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
[TBL] [Abstract][Full Text] [Related]
4. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
5. CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
Yuan H; Lauritsen CG; Kaiser EA; Silberstein SD
BioDrugs; 2017 Dec; 31(6):487-501. PubMed ID: 29116598
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
Yuan H; White CS; Silberstein SD
Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
[TBL] [Abstract][Full Text] [Related]
7. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
8. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion.
Lin YT; Yu Z; Tsai SC; Hsu PH; Chen JC
J Headache Pain; 2020 Jul; 21(1):87. PubMed ID: 32640973
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
Bigal ME; Walter S
CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-Successful translation of basic science to clinical practice.
Edvinsson L
J Intern Med; 2022 Oct; 292(4):575-586. PubMed ID: 35532284
[TBL] [Abstract][Full Text] [Related]
12. Role of CGRP in Migraine.
Edvinsson L
Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
[TBL] [Abstract][Full Text] [Related]
13. Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.
Friedrich N; Németh K; Tanner M; Rosta J; Dobos I; Oszlács O; Jancsó G; Messlinger K; Dux M
J Headache Pain; 2024 Jan; 25(1):9. PubMed ID: 38243174
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
Cohen F; Yuan H; Silberstein SD
BioDrugs; 2022 May; 36(3):341-358. PubMed ID: 35476215
[TBL] [Abstract][Full Text] [Related]
15. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
Pellesi L; Guerzoni S; Pini LA
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
18. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
[TBL] [Abstract][Full Text] [Related]
19. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
